Published in Am J Cardiol on May 15, 1990
Amiodarone-induced cirrhosis of liver: what predicts mortality? ISRN Cardiol (2013) 0.87
Creatinine elevation in patients receiving amiodarone correlates with serum amiodarone concentration. Br J Clin Pharmacol (1993) 0.85
Recommendations from the Canadian Hypertension Society Consensus Conference on the Pharmacologic Treatment of Hypertension. CMAJ (1989) 4.76
Clinical pharmacologic observations on atenolol, a beta-adrenoceptor blocker. Clin Pharmacol Ther (1976) 3.16
Xylazine hydrochloridine (Rompun) overdose in man. Clin Toxicol (1979) 2.00
Adenosine for paroxysmal supraventricular tachycardia: dose ranging and comparison with verapamil. Assessment in placebo-controlled, multicenter trials. The Adenosine for PSVT Study Group. Ann Intern Med (1990) 1.91
Quality parameters of mango and potential of non-destructive techniques for their measurement - a review. J Food Sci Technol (2010) 1.85
Blood levels of practolol after oral and parenteral administration and their relationship to exercise heart rate. Clin Pharmacol Ther (1974) 1.81
Influence of intrinsic sympathomimetic activity and cardioselectivity on beta adrenoceptor blockade. Clin Pharmacol Ther (1977) 1.77
The diagnostic sensitivity of electrophysiologic testing in patients with syncope caused by transient bradycardia. N Engl J Med (1989) 1.72
Observations on the efficacy and pharmacokinetics of sotalol after oral administration. Eur J Clin Pharmacol (1976) 1.71
Longitudinal electrophysiologic assessment of asymptomatic patients with the Wolff-Parkinson-White electrocardiographic pattern. N Engl J Med (1989) 1.67
Evaluation of cyclosporin-phenytoin interaction with observations on cyclosporin metabolites. Br J Clin Pharmacol (1984) 1.66
Reversible shear-mediated platelet dysfunction during cardiac surgery as assessed by the PFA-100 platelet function analyzer. Blood Coagul Fibrinolysis (2001) 1.50
Asymptomatic Wolff-Parkinson-White. Should we intervene? Circulation (1989) 1.47
Termination of acute atrial fibrillation in the Wolff-Parkinson-White syndrome by procainamide and propafenone: importance of atrial fibrillatory cycle length. J Am Coll Cardiol (1990) 1.46
Plasma digoxin concentrations in patients on admission to hospital. Br Heart J (1974) 1.46
Results of operative therapy in the permanent form of junctional reciprocating tachycardia. Am J Cardiol (1989) 1.39
Simplified liquid-chromotographic analysis for cyclosporin A, and comparison with radioimmunoassay. Clin Chem (1983) 1.38
Duration of action of beta-blocking drugs. Br Med J (1973) 1.33
Variability in prescription drug utilization: issues for research. CMAJ (1996) 1.24
Atrial fibrillation in patients with Wolff-Parkinson-White syndrome: incidence after surgical ablation of the accessory pathway. Circulation (1985) 1.21
Characteristics of accessory pathways exhibiting decremental conduction. Am J Cardiol (1991) 1.15
Quinidine-rifampin interaction. N Engl J Med (1981) 1.14
The coronary sinus diverticulum: a pathologic entity associated with the Wolff-Parkinson-White syndrome. Am J Cardiol (1988) 1.14
Measurement of partial agonist activity of pindolol. Clin Pharmacol Ther (1981) 1.13
Correlation of reduction of exercise heart rate with blood levels of atenolol after oral and intravenous administration. Postgrad Med J (1977) 1.13
Phenytoin-theophylline interaction. N Engl J Med (1982) 1.10
Reflex mechanisms responsible for early spontaneous termination of paroxysmal supraventricular tachycardia. Am J Cardiol (1982) 1.10
Closed-heart technique for Wolff-Parkinson-White syndrome: further experience and potential limitations. Ann Thorac Surg (1986) 1.09
Alpha adrenergic-mediated accumulation of calcium in reperfused myocardium. J Clin Invest (1983) 1.09
Treatment of pruritus in primary biliary cirrhosis with rifampin. Results of a double-blind, crossover, randomized trial. Gastroenterology (1988) 1.08
Cardiac dose-response relationships of oral and intravenous pindolol. Br J Clin Pharmacol (1982) 1.08
Prediction of defibrillation success from a single defibrillation threshold measurement with sequential pulses and two current pathways in humans. Circulation (1988) 1.04
Relationships between heart rate and PR interval during physiological and pharmacological interventions. Br J Clin Pharmacol (1987) 1.03
An audit of requests for therapeutic drug monitoring of digoxin: problems and pitfalls. Ther Drug Monit (1983) 1.03
Grapefruit juice--felodipine interaction in the elderly. Clin Pharmacol Ther (2000) 1.01
Severe coughing during captopril and enalapril therapy. CMAJ (1986) 1.01
Evaluation and application of the linear variable differential transformer technique for the assessment of human dorsal hand vein alpha-receptor activity. Clin Pharmacol Ther (1985) 1.00
Correlation between plasma diphenhydramine level and sedative and antihistamine effects. Clin Pharmacol Ther (1978) 0.99
A study of efficacy, tolerance and compliance of once-daily versus twice-daily metoprolol (Betaloc) in hypertension. Betaloc Compliance Canadian Cooperative Study Group. Clin Invest Med (1984) 0.97
Tolerance and cardiovascular effects of single dose felodipine/beta-blocker combinations in healthy subjects. J Cardiovasc Pharmacol (1987) 0.97
"Nodoventricular" accessory pathway: evidence for a distinct accessory atrioventricular pathway with atrioventricular node-like properties. J Am Coll Cardiol (1988) 0.97
Multicenter comparison of truncated biphasic shocks and standard damped sine wave monophasic shocks for transthoracic ventricular defibrillation. Transthoracic Investigators. Circulation (1996) 0.96
Demonstration of macroreentry and feasibility of operative therapy in the common type of atrial flutter. Am J Cardiol (1986) 0.95
Relation between clinical presentation and induced arrhythmias in the Wolff-Parkinson-White syndrome. Am J Cardiol (1987) 0.95
Impaired enzyme induction by rifampicin in the elderly. Br J Clin Pharmacol (1984) 0.95
A secondary prevention, randomized trial of suloctidil in patients with a recent history of thromboembolic stroke. Stroke (1985) 0.93
Increased venous alpha-adrenoceptor responsiveness in patients with reflex sympathetic dystrophy. Ann Intern Med (1993) 0.93
Vagal techniques for termination of paroxysmal supraventricular tachycardia. Am J Cardiol (1980) 0.92
Cyclosporin-erythromycin interaction in normal subjects. Br J Clin Pharmacol (1987) 0.92
An algorithm for the electrocardiographic localization of accessory pathways in the Wolff-Parkinson-White syndrome. Pacing Clin Electrophysiol (1987) 0.91
Acceleration of the ventricular response during atrial fibrillation in the Wolff-Parkinson-White syndrome after verapamil. Circulation (1982) 0.91
The protective effect of vagus nerve stimulation on catecholamine-halothane-induced ventricular fibrillation in dogs. Can J Physiol Pharmacol (1989) 0.91
Respiratory and cardiac effects of metoprolol and bevantolol in patients with asthma. Clin Pharmacol Ther (1986) 0.91
Sensitivity and specificity of invasive and noninvasive testing for risk of sudden death in Wolff-Parkinson-White syndrome. J Am Coll Cardiol (1987) 0.90
Mean apical concentration and duration in the comparative bioavailability of slowly absorbed and eliminated drug preparations. J Pharm Sci (1988) 0.89
Mode of onset of atrial fibrillation in the Wolff-Parkinson-White syndrome: how important is the accessory pathway? J Am Coll Cardiol (1990) 0.88
Surgery for Wolff-Parkinson-White syndrome: further experience with an epicardial approach. Circulation (1986) 0.88
Concealed conduction in accessory atrioventricular pathways: an important determinant of the expression of arrhythmias in patients with Wolff-Parkinson-White syndrome. Circulation (1984) 0.87
The influence of age on dorsal hand vein responsiveness to norepinephrine. Clin Pharmacol Ther (1986) 0.87
Electrophysiologic profile of asymptomatic Wolff-Parkinson-White pattern. Am J Cardiol (1986) 0.87
Simplified liquid-chromatographic assay of amiodarone and desethylamiodarone after solid-phase extraction. Clin Chem (1986) 0.86
Digoxin therapy during T-tube biliary drainage in man. JAMA (1978) 0.86
ANP, BNP, and CNP enhance bradycardic responses to cardiopulmonary chemoreceptor activation in conscious sheep. Am J Physiol Regul Integr Comp Physiol (2001) 0.86
Comparison of the ventricular response during atrial fibrillation in patients with enhanced atrioventricular node conduction and Wolff-Parkinson-White syndrome. J Am Coll Cardiol (1987) 0.86
Creatinine elevation in patients receiving amiodarone correlates with serum amiodarone concentration. Br J Clin Pharmacol (1993) 0.85
Valsalva termination of ventricular tachycardia. Circulation (1980) 0.85
Cryosurgical modification of the atrioventricular node: a closed heart approach in the dog. J Am Coll Cardiol (1987) 0.84
Lysophosphoglycerides and ventricular fibrillation early after onset of ischemia. J Mol Cell Cardiol (1987) 0.84
Initial clinical experience with the pacemaker-cardioverter-defibrillator. Can J Cardiol (1990) 0.83
Operative therapy of atrioventricular node reentry and results of an anatomically guided procedure. Am J Cardiol (1989) 0.83
Correlation of amiodarone dosage, heart rate, QT interval and corneal microdeposits with serum amiodarone and desethylamiodarone concentrations. Am J Cardiol (1989) 0.83
Effect of adrenergic stimulation and blockade on ventricular defibrillation in the rat. J Pharmacol Exp Ther (1983) 0.83
Cross-talk in bipolar pacemakers. Pacing Clin Electrophysiol (1989) 0.83
Cholestyramine and spironolactone and their combination in digitoxin elimination. Clin Pharmacol Ther (1980) 0.82
Influences of labetalol a combined alpha- and beta-adrenergic blocking agent on the dysrhythmias induced by coronary occlusion and reperfusion. Cardiovasc Res (1982) 0.82
Surgical ablation of posterior septal accessory pathways in the Wolff-Parkinson-White syndrome by a closed heart technique. J Thorac Cardiovasc Surg (1986) 0.82
Familial studies of heritability of alpha1-adrenergic receptor responsiveness in superficial veins. Clin Pharmacol Ther (1997) 0.82
Localization of accessory pathways in the Wolff-Parkinson-White syndrome. Pacing Clin Electrophysiol (1989) 0.82
Genetic aspects of variability in superficial vein responsiveness to norepinephrine. Clin Pharmacol Ther (1991) 0.82
Ineffectiveness of beta-adrenergic blockers on ventilatory response to carbon dioxide. Clin Pharmacol Ther (1982) 0.81
Comparative effects of adenosine triphosphate on accessory pathway and atrioventricular nodal conduction. Am Heart J (1988) 0.81
Adrenergic factors in arrhythmogenesis in the ischemic and reperfused myocardium. Eur Heart J (1983) 0.81
Defibrillation threshold: a simple and quantitative estimate of the ability to defibrillate. Pacing Clin Electrophysiol (1987) 0.79
Surgery for the Wolff-Parkinson-White syndrome: the epicardial approach. Semin Thorac Cardiovasc Surg (1989) 0.79
Nonclinical ventricular tachycardia in the Wolff-Parkinson-White syndrome. Pacing Clin Electrophysiol (1985) 0.79
Internal cardiac defibrillation in man: pronounced improvement with sequential pulse delivery to two different lead orientations. Circulation (1986) 0.79
Electrophysiologic effects and long-term efficacy of bepridil for recurrent supraventricular tachycardias. Am J Cardiol (1987) 0.78
Diagnostic assessment of recurrent syncope. Pacing Clin Electrophysiol (1984) 0.78
Adrenergic effects on internal cardiac defibrillation threshold. Am J Physiol (1987) 0.78
Improved hepatic differentiation strategies for human induced pluripotent stem cells. Curr Mol Med (2013) 0.78
Defibrillation with the sequential pulse technique: reproducibility with repeated shocks. Am Heart J (1986) 0.77
Surgical treatment of supraventricular tachycardia: a five-year experience. Pacing Clin Electrophysiol (1986) 0.77
Platelet glycoprotein IIb/IIIa antagonists: perioperative implications. J Cardiothorac Vasc Anesth (2001) 0.77
Skeletonization of the atrioventricular node for AV node reentrant tachycardia: experience with 32 patients. Ann Thorac Surg (1990) 0.77